Online cognitive testing for people with Parkinson's disease
Official title: Deep Cognitive Endophenotyping of Parkinson's Disease: A Platform Development and Pilot Study
Run by McGill University · NCT05025254 · Data updated 2026-11-12
This study is testing if online cognitive tests can be reliable and helpful for people with Parkinson's disease.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years to 90 Years |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | McGill University Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | August 2021 |
| Main results expected | September 2022 |
| Study ends | December 2026 |
| Registry record updated | August 27, 2021 |
| Trial ID | NCT05025254 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with Parkinson's disease or healthy individuals without any neurological illnesses.
✕Probably not a fit
Patients with psychotic disorders, advanced dementia, or other significant neurological conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to assess the feasibility and reliability of conducting large-scale online neurocognitive testing specifically for individuals with Parkinson's disease. It will involve both in-lab and online testing to validate the effectiveness of these cognitive assessments. The study seeks to establish a protocol for future research in this area, which has not been extensively explored in Parkinson's research despite its growing use in psychiatry.
Why it matters
Potential benefit: If successful, this study could lead to more accessible and effective cognitive assessments for patients with Parkinson's disease.
How similar studies have gone: While large-scale online cognitive testing has been successful in psychiatry, this approach in Parkinson's research is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of Parkinson's disease by neurologist or healthy individual with no diagnosis of any neurological illness Exclusion Criteria: * Psychotic spectrum disorders, active uncontrolled depression, advanced dementia (i.e. needing assistance with daily activities such as dressing or bathing), major stroke, major head injury, epilepsy requiring anti-seizure medications
Where it's running
-
McGill University Health Centre
Montreal, Quebec, Canada Recruiting
Study contacts
- Principal investigator: Madeleine Sharp, MD — McGill University
- Study coordinator: Madeleine Sharp, MD
- Email: madeleine.sharp@mcgill.ca
- Phone: 514-398-5174
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.